| Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
|---|
| 06/08/2005 | EP1536766A1 Method for protecting the skin from aging |
| 06/08/2005 | EP1536753A1 Method for protecting and for modulating dermal-epidermal junctions |
| 06/08/2005 | EP1536751A2 Use of a genus i halopteris /i brown alga extract in a cosmetic or pharmaceutical composition for limiting adipose tissue expansion and corresponding cosmetic or pharmaceutical composition |
| 06/08/2005 | EP1536697A1 Composition containing in combination at least one gourd oil and at least one borage oil, use thereof as medicine, as dermatological or dermato-cosmetic agent |
| 06/08/2005 | EP1414937B1 Hops extracts, method for the production and use |
| 06/08/2005 | EP1265595B1 Stabilized ascorbic acid solutions |
| 06/08/2005 | EP1206488B1 Method for isolating and purifying grass pollen allergens |
| 06/08/2005 | EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition |
| 06/08/2005 | CN1625422A Synergistic cocomposition of trans-24-15-carbonyl acid and apocynin and its application |
| 06/08/2005 | CN1625408A Improved kavalactone profile |
| 06/08/2005 | CN1625406A Formulation containing (lyso-) phosphatidylserine for the prevention and treatment of stress states in warm-blooded animals |
| 06/08/2005 | CN1625395A Lutein/zeaxanthin for glare protection |
| 06/08/2005 | CN1205222C Method for isolating and purifying grass pollen allergens |
| 06/07/2005 | US6903136 Food supplements containing 4-hydroxyisoleucine and creatine |
| 06/07/2005 | US6902748 Medicines manufactured from old platycodon extracts |
| 06/07/2005 | US6902739 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders |
| 06/02/2005 | WO2005049086A1 Yeast compositions and their uses as dietary supplement or medicine |
| 06/02/2005 | WO2005049060A1 Composition and method for treatment of acne |
| 06/02/2005 | WO2005049059A1 Perfume for improving the behavior of demented elders |
| 06/02/2005 | WO2005049058A1 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases |
| 06/02/2005 | WO2005049057A1 Use of cassia sophera linn. for treating diabetes |
| 06/02/2005 | WO2005049053A1 Composition comprising a magnesium compound and/or a magnesium saltfor improving sexual dysfunction |
| 06/02/2005 | WO2005049046A1 Hypotensive drug and process for producing the same |
| 06/02/2005 | WO2005049001A1 Anti-tumour terpene compounds |
| 06/02/2005 | WO2005048994A1 New formulation for retinoid-containing soft gelatin capsules |
| 06/02/2005 | WO2005048950A2 Tumor and infectious disease therapeutic compositions |
| 06/02/2005 | WO2005048940A2 Nutraceutical mangosteen tea |
| 06/02/2005 | WO2005048934A2 Mangosteen protein supplement |
| 06/02/2005 | WO2005048931A2 Dissolving thin film xanthone supplement |
| 06/02/2005 | WO2005048929A2 Plant-derived protein extract compositions and methods |
| 06/02/2005 | WO2005048919A2 Preventative effects of morinda citrifolia on mammary breast cancer |
| 06/02/2005 | WO2005048915A2 Renoprotective and lipid lowering oral compositions |
| 06/02/2005 | WO2005048870A2 Compositions for oral health in animals |
| 06/02/2005 | WO2005048719A1 Polyphenol-containing stem and vine extracts and methods of use |
| 06/02/2005 | WO2005033276A3 Process for producing natural surfactants and compositions based on natural surfactants |
| 06/02/2005 | US20050118312 product as useful in ameliorating symptoms associated with menopause comprising pomegranate seed oil product and pomegranate fruit or juice product |
| 06/02/2005 | US20050118294 Composition for weight reduction comprising water-soluble low-molecular weight chitosan and hibiscus extract |
| 06/02/2005 | US20050118293 Extracting native mate plant material using supercritical CO2 conditions to obtain a mate formulation comprising at least one at level one predetermined characteristic |
| 06/02/2005 | US20050118292 Dioscorea extracts |
| 06/02/2005 | US20050118291 Synergistic Effects; preventative effects of Morinda citrifolia-containing compounds on mammary gland tumorigenesis |
| 06/02/2005 | US20050118290 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases |
| 06/02/2005 | US20050118289 Process for producing fat composition containing hydrophobic components of glycyrrhiza |
| 06/02/2005 | US20050118288 Method for producing high-quality hydropbic licorice extract |
| 06/02/2005 | US20050118286 comprising an anticonvulsant and a neuroactive modulator; eg childhood disorders, cognitive disorders, substance disorders, schizophrenia, psychotic disorders mood disorders, anxiety disorders, somatoform disorders, factitious disorders, dissociative disorders, sexual disorders, gender identity disorders |
| 06/02/2005 | US20050118285 O/W emulsion containing aloe vera, uses thereof, method for making |
| 06/02/2005 | US20050118284 Soluble isoflavone compositions |
| 06/02/2005 | US20050118283 Skincare compositions and methods |
| 06/02/2005 | US20050118282 Compositions and methods for inhibiting 5-alpha reductase |
| 06/02/2005 | US20050118262 Controlled release formulation |
| 06/02/2005 | US20050118215 green tea extract, grape seed extract, 1,3-butylene glycol; topical composition |
| 06/02/2005 | US20050118133 Active agent mixture containing a plant extract of convolvulaceae |
| 06/02/2005 | DE10352602A1 Kosmetisches oder therapeutisches Kombinationspräparat Cosmetic or therapeutic combination product |
| 06/02/2005 | CA2545819A1 Nutraceutical mangosteen tea |
| 06/02/2005 | CA2545788A1 Plant-derived protein extract compositions and methods |
| 06/02/2005 | CA2545717A1 Anti-tumour terpene compounds |
| 06/02/2005 | CA2537300A1 Treatment of asprin resistance with radix salviae miltiorrhizae, its extract and composition |
| 06/02/2005 | CA2533884A1 Preventative effects of morinda citrifolia on mammary breast cancer |
| 06/01/2005 | EP1535619A1 Poria extract devoid of secolanostane derivatives comprising lanostane derivatives for immunity enhancement |
| 06/01/2005 | EP1534682A1 Novel molecules derived from noraporphine |
| 06/01/2005 | EP1534295A1 Formulations and methods of administration of cephalotaxines, including homoharringtonine |
| 06/01/2005 | EP1534261A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 06/01/2005 | EP1534082A1 Powder or extracts of plant leaves with anti-obesity effects and anti-obesity food comprising them |
| 06/01/2005 | EP1534076A1 Fungicide composition containing tea tree oil |
| 06/01/2005 | EP1253904B1 Use of extracts from residues left in the production of wine as cosmetic care actives for skin and hair |
| 06/01/2005 | EP1131061B1 Agent for lowering prolactin |
| 06/01/2005 | EP0973494B1 Use of an extract of the genus adansonia |
| 06/01/2005 | EP0873110B1 Improved hemostatic composition for treating gingival area |
| 06/01/2005 | CN1622991A Fermented herbal health drink from plant andrographis |
| 06/01/2005 | CN1622820A Therapeutic cream for dermatitis |
| 06/01/2005 | CN1622819A An anti-rheumatism medicament and preparation method thereof |
| 06/01/2005 | CN1622818A Therapeutic lotion for dermatitis |
| 06/01/2005 | CN1622817A Drinking tea for treating dermatitis |
| 06/01/2005 | CN1622796A Topical anti-inflammatory compositions and methods of reducing inflammation |
| 06/01/2005 | CN1622760A A process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent |
| 06/01/2005 | CN1622755A Antiviral composition derived from allium cepa and therapeutic use thereof |
| 06/01/2005 | CN1203863C Use of pet food compositions containing fermentable fiber |
| 05/31/2005 | US6900242 Compound for use in the treatment of cancer and prevention of infections |
| 05/31/2005 | US6900241 Compositions for, and methods of, treating atherosclerosis |
| 05/31/2005 | US6900240 Enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids. |
| 05/31/2005 | US6900173 Mixture containing digestion enzyme, vitamins, amino acid |
| 05/31/2005 | US6899903 Antiinflammatory agents; respiratory system disorders; spraying mixture of herbs, colloidal silver, grapefruit seed extract and preservative |
| 05/31/2005 | US6899901 Cooling or heating sensitizers such as oleoresin or spilanthol, for use in foods, drugs or cosmetics |
| 05/31/2005 | US6899891 Nutritional composition, methods of producing said composition and methods of using said composition |
| 05/31/2005 | US6899700 Therapeutic agent delivery tampon |
| 05/26/2005 | WO2005047548A1 Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals |
| 05/26/2005 | WO2005046796A2 Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels |
| 05/26/2005 | WO2005046706A1 Lipometabolism improver containing pine bark extract |
| 05/26/2005 | WO2005046705A1 Use of additionally fermented distillers grains for preventing and/or treating increased blood sugar values |
| 05/26/2005 | WO2005046704A1 Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 05/26/2005 | WO2005046702A1 Method of inhibiting alveolar resorption and peridental membrane loss and composition for internal use to be used therein |
| 05/26/2005 | WO2005046623A1 Combined cosmetic or therapeutic preparation |
| 05/26/2005 | WO2005046584A2 Stimulation of hair growth by ginkgo biloba flavanoids |
| 05/26/2005 | WO2005046574A2 Compositions containing melon extracts |
| 05/26/2005 | WO2005046363A2 Tobacco compositions |
| 05/26/2005 | WO2005046358A1 Method of using whole olive and food having activity against helicobacter pylori |
| 05/26/2005 | WO2005027951B1 Method for controlling angiogenesis in animals |
| 05/26/2005 | WO2005000331A3 Compositions for the treatment and prevention of degenerative joint disorders |
| 05/26/2005 | WO2003004039A9 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 05/26/2005 | US20050113316 Process for producing dammarane sapogenins and ginsenosides |
| 05/26/2005 | US20050113312 2-0-(-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containning compositions comprising it |